The Procter & Gamble Company (NYSE:PG) Shares Acquired by LaFleur & Godfrey LLC

LaFleur & Godfrey LLC lifted its stake in shares of The Procter & Gamble Company (NYSE:PG) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 55,102 shares of the company’s stock after acquiring an additional 1,689 shares during the quarter. Procter & Gamble comprises about 1.2% of LaFleur & Godfrey LLC’s investment portfolio, making the stock its 27th biggest holding. LaFleur & Godfrey LLC’s holdings in Procter & Gamble were worth $8,075,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Wyrmwood Management LLC acquired a new position in Procter & Gamble in the fourth quarter worth approximately $29,000. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble in the second quarter worth approximately $50,000. CGC Financial Services LLC acquired a new position in Procter & Gamble in the second quarter worth approximately $55,000. VitalStone Financial LLC acquired a new position in Procter & Gamble in the second quarter worth approximately $60,000. Finally, RVW Wealth LLC acquired a new position in Procter & Gamble in the third quarter worth approximately $77,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Marc S. Pritchard sold 101,704 shares of the business’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the transaction, the insider now owns 163,428 shares in the company, valued at $25,097,637.96. The disclosure for this sale can be found here. Insiders have sold a total of 279,063 shares of company stock valued at $43,187,745 over the last quarter. 0.17% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Royal Bank of Canada lifted their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. Stifel Nicolaus lifted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Raymond James lifted their price objective on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Finally, The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $168.41.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded down $0.40 on Thursday, hitting $162.21. 2,719,350 shares of the company were exchanged, compared to its average volume of 6,834,280. The firm has a market capitalization of $381.68 billion, a price-to-earnings ratio of 27.18, a PEG ratio of 3.28 and a beta of 0.44. The company’s 50 day moving average price is $158.17 and its two-hundred day moving average price is $152.09. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $163.14. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.44 and a current ratio of 0.64.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. The business had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.59 earnings per share. Research analysts expect that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were paid a $0.9407 dividend. The ex-dividend date was Thursday, January 18th. This represents a $3.76 dividend on an annualized basis and a yield of 2.32%. Procter & Gamble’s payout ratio is currently 62.98%.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.